BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sankhe R, Rathi E, Manandhar S, Kumar A, Pai SRK, Kini SG, Kishore A. Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study. J Mol Struct 2021;1224:129073. [PMID: 32834116 DOI: 10.1016/j.molstruc.2020.129073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Rex DAB, Arun Kumar ST, Modi PK, Keshava Prasad TS. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target? OMICS 2021;25:408-16. [PMID: 34191617 DOI: 10.1089/omi.2021.0080] [Reference Citation Analysis]
2 Manandhar S, Sankhe R, Priya K, Hari G, Kumar B H, Mehta CH, Nayak UY, Pai KSR. Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer's disease. Mol Divers 2022. [PMID: 35146638 DOI: 10.1007/s11030-022-10395-8] [Reference Citation Analysis]
3 Ojha M, Kumar A, Prasun C, Nair MS, Chaturvedi S, Paliwal SK, Nain S. Synthesis, characterization, and in silico studies of 1,8-naphthyridine derivatives as potential anti-Parkinson's agents. J Biomol Struct Dyn 2021;:1-16. [PMID: 34895067 DOI: 10.1080/07391102.2021.2013320] [Reference Citation Analysis]
4 Sankhe R, Pai SRK, Kishore A. Tumour suppression through modulation of neprilysin signaling: A comprehensive review. Eur J Pharmacol 2021;891:173727. [PMID: 33160935 DOI: 10.1016/j.ejphar.2020.173727] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Akbar S, Das S, Iqubal A, Ahmed B. Synthesis, biological evaluation and molecular dynamics studies of oxadiazine derivatives as potential anti-hepatotoxic agents. J Biomol Struct Dyn 2021;:1-18. [PMID: 34180365 DOI: 10.1080/07391102.2021.1938233] [Reference Citation Analysis]
6 Haider K, Ahmad K, Najmi AK, Das S, Joseph A, Shahar Yar M. Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors. Archiv der Pharmazie. [DOI: 10.1002/ardp.202200146] [Reference Citation Analysis]
7 B M, Manandhar S, Hari G, Priya K, Kumar B H, Pai KSR. Virtual structure-based docking, WaterMap, and molecular dynamics guided identification of the potential natural compounds as inhibitors of protein-tyrosine phosphatase 1B. Journal of Molecular Structure 2021;1226:129396. [DOI: 10.1016/j.molstruc.2020.129396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Westmark CJ, Filon MJ, Maina P, Steinberg LI, Ikonomidou C, Westmark PR. Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model. Cells 2022;11:1350. [DOI: 10.3390/cells11081350] [Reference Citation Analysis]
9 Halder D, Das S, Joseph A, Jeyaprakash RS. Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha. J Biomol Struct Dyn 2022;:1-14. [PMID: 35285757 DOI: 10.1080/07391102.2022.2050948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]